title: Cysteine substitution of transmembrane domain amino acids alters the ethanol inhibition of GluN1/GluN2A N-methyl-D-aspartate receptors.
abstract: N-Methyl-d-aspartate receptors (NMDARs) are inhibited by behaviorally relevant concentrations of ethanol, and residues within transmembrane (TM) domains of NMDARs, including TM3 GluN1 phenylalanine 639 (F639), regulate this sensitivity. In the present study, we used cysteine (C) mutagenesis to determine whether there are additional residues within nearby TM domains that regulate ethanol inhibition on NMDARs. GluN1(F639C)/GluN2A receptors were less inhibited by ethanol than wild-type receptors, and inhibition was restored to wild-type levels following treatment with ethanol-like methanethiosulfonate reagents. Molecular modeling identified six residues in the GluN1 TM1 domain (valine V566; serine S569) and the GluN2A TM4 domain (methionine, M817; V820, F821, and leucine, L824) that were in close vicinity to the TM3 F639 residue, and these were individually mutated to cysteine and tested for ethanol inhibition and receptor function. The F639C-induced decrease in ethanol inhibition was blunted by coexpression of GluN1 TM1 mutants V566C and S569C, and statistically significant interactions were observed for ethanol inhibition among V566C, F639C, and GluN2A TM4 mutants V820C and F821C and S569C, F639C, and GluN2A TM4 mutants F821C and L824C. Ethanol inhibition was also reduced when either GluN1 TM1 mutant V566C or S569C was combined with GluN2A V820C, suggesting a novel TM1:TM4 intrasubunit site of action for ethanol. Cysteines substituted at TM3 and TM4 sites previously suggested to interact with ethanol had less dramatic effects on ethanol inhibition. Overall, the results from these studies suggest that interactions among TM1, TM3, and TM4 amino acids in NMDARs are important determinants of ethanol action at these receptors.
authors: Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina.
authors: Minfu
authors: M
authors: Xu
authors: Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina.
authors: C Thetford
authors: CT
authors: Smothers
authors: Department of Neuroscience, Medical University of South Carolina, Charleston, South Carolina woodward@musc.edu.
authors: John J
authors: JJ
authors: Woodward
mesh_terms: D019943:Amino Acid Substitution; D003545:Cysteine / Q000235:genetics; D000431:Ethanol / Q000494:pharmacology*; D057809:HEK293 Cells; D006801:Humans; D008958:Models, Molecular; D009154:Mutation; D018408:Patch-Clamp Techniques; D017434:Protein Structure, Tertiary; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism
chemical_list: D003545:Cysteine; D000431:Ethanol; D016194:Receptors, N-Methyl-D-Aspartate; C409466:NR1 NMDA receptor
references: Brain Res. 1996 Nov 4;738(2):249-56
references: 8955520
references: J Biol Chem. 2001 Nov 30;276(48):44729-35
references: 11572853
references: Br J Pharmacol. 1997 Nov;122(6):1035-42
references: 9401766
references: Neuron. 1999 Mar;22(3):559-70
references: 10197535
references: Nature. 2005 Nov 10;438(7065):185-92
references: 16281028
references: Alcohol Clin Exp Res. 2006 Mar;30(3):523-30
references: 16499494
references: J Pharmacol Exp Ther. 2006 Jul;318(1):434-43
references: 16622040
references: J Neurosci. 2008 Feb 13;28(7):1546-56
references: 18272676
references: Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9305-10
references: 10908659
references: Nature. 2014 Jul 10;511(7508):191-7
references: 25008524
references: J Neurosci. 2002 Mar 15;22(6):2044-53
references: 11896144
references: J Biol Chem. 2003 Dec 5;278(49):48815-20
references: 14506267
references: Neuropharmacology. 2004 Apr;46(5):647-54
references: 14996542
references: Pflugers Arch. 1981 Aug;391(2):85-100
references: 6270629
references: J Neurochem. 1990 Feb;54(2):712-5
references: 2405104
references: J Neurochem. 1995 Jul;65(1):140-8
references: 7540660
references: Neuropharmacology. 1995 Mar;34(3):347-55
references: 7630488
references: Pharmacol Rev. 2009 Mar;61(1):98-114
references: 19270242
references: Alcohol Clin Exp Res. 2009 Jun;33(6):945-69
references: 19302091
references: Nature. 2009 Dec 10;462(7274):745-56
references: 19946266
references: Pharmacol Rev. 2010 Sep;62(3):405-96
references: 20716669
references: J Neurosci. 2010 Sep 1;30(35):11792-804
references: 20810899
references: PLoS One. 2011;6(4):e19180
references: 21544205
references: J Gen Physiol. 2011 Aug;138(2):179-94
references: 21746848
references: Nat Commun. 2011;2:498
references: 21988914
references: J Pharmacol Exp Ther. 2012 Jan;340(1):218-26
references: 22005043
references: Curr Top Behav Neurosci. 2013;13:87-126
references: 21877259
references: J Biol Chem. 2012 Aug 10;287(33):27302-12
references: 22715100
references: J Neurosci. 2013 Jul 17;33(29):12052-66
references: 23864691
references: PLoS One. 2013;8(11):e80541
references: 24244696
references: J Neurochem. 2014 Feb;128(3):363-75
references: 24117469
references: Science. 2014 May 30;344(6187):992-7
references: 24876489
references: J Neurosci. 1997 Aug 1;17(15):5711-25
references: 9221770